Comparison of the Mediterranean Diet and Other Therapeutic Strategies in Metabolic Syndrome: A Systematic Review and Meta-Analysis
- PMID: 40565352
- PMCID: PMC12192665
- DOI: 10.3390/ijms26125887
Comparison of the Mediterranean Diet and Other Therapeutic Strategies in Metabolic Syndrome: A Systematic Review and Meta-Analysis
Abstract
The Mediterranean diet (MD) is one of the healthiest diets, high in fiber, antioxidants, and unsaturated fats. MD improves lipid profiles, reduces inflammation, controls blood pressure, decreases insulin resistance, and enhances the sensitivity to this hormone, lowering the risks of Metabolic syndrome (MS). MS is characterized by central obesity, hypertension, insulin resistance, and dyslipidemia, increasing the risk of cardiovascular disease and type II diabetes. The objective of this study was to know the effectiveness of the MD versus other treatments in patients with MS. A systematic search across multiple databases, Medline, Embase, Web of Science, Scopus, Google Scholar, and Cinahl, was conducted using keywords such as "Mediterranean diet", "Mediterranean food", "eat mediterranean", "Metabolic syndrome", and "x syndrome". A total of 12 studies met the inclusion criteria. Mediterranean diet at different doses versus other diets or other treatments showed significant improvements in clinical parameters, including BMI (mean difference of -0.83 95% CI: -0.93 to -0.74; p < 0.00001),waist circumference (mean difference = -1.81, CI = -2.63 to -0.99, p < 0.00001) triglycerides (mean difference = -22.38, CI = -32.86 to -11.90, p < 0.00001), Glucose (mean difference = -4.28, CI = -7.64 to -0.93, p = 0.005) and, HOMA IR (mean difference = -0.72, CI = -0.78 to -0.65, p < 0.00001), and Insulin resistance (mean difference = -2.98, CI = -3.27 to -2.69, p < 0.00001), all of which improved, Although there were more outcomes, these are the most important changes for patients with metabolic syndrome. MD improves metabolic and cardiovascular health, but study heterogeneity limits the results' generalizability. Because of that, further research is needed to standardize approaches and explore their mechanisms. MD should be part of an optimized strategy that includes education and physical activity. The strength of the evidence was very low according to the GRADE approach. Further research is needed to support the efficacy of the Mediterranean diet in patients with MS.
Keywords: eat mediterranean; mediterranean diet; mediterranean food; metabolic syndrome; x syndrome.
Conflict of interest statement
The authors of this research declare that they have no conflicts of interest in this research.
Figures
















Similar articles
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 Jan 9;1:CD011535. doi: 10.1002/14651858.CD011535.pub3. PMID: 29271481 Free PMC article. Updated.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
-
Nutritional interventions for survivors of childhood cancer.Cochrane Database Syst Rev. 2016 Aug 22;2016(8):CD009678. doi: 10.1002/14651858.CD009678.pub2. Cochrane Database Syst Rev. 2016. PMID: 27545902 Free PMC article.
-
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2. Cochrane Database Syst Rev. 2020. PMID: 33075160 Free PMC article.
-
Effects of a gluten-reduced or gluten-free diet for the primary prevention of cardiovascular disease.Cochrane Database Syst Rev. 2022 Feb 24;2(2):CD013556. doi: 10.1002/14651858.CD013556.pub2. Cochrane Database Syst Rev. 2022. PMID: 35199850 Free PMC article.
References
-
- Esposito K., Marfella R., Ciotola M., Di Palo C., Giugliano F., Giugliano G., D’Armiento M., D’Andrea F., Giugliano D. Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: A randomized trial. JAMA. 2004;292:1440–1446. doi: 10.1001/jama.292.12.1440. - DOI - PubMed
-
- Asoudeh F., Fallah M., Aminianfar A., Djafarian K., Shirzad N., Clark C.C.T., Larijani B., Esmaillzadeh A. The effect of Mediterranean diet on inflammatory biomarkers and components of metabolic syndrome in adolescent girls. J. Endocrinol. Investig. 2023;46:1995–2004. doi: 10.1007/s40618-023-02027-1. Erratum in J. Endocrinol. Investig. 2024, 47, 257. - DOI - PubMed
-
- Mayneris-Perxachs J., Sala-Vila A., Chisaguano M., Castellote A.I., Estruch R., Covas M.I., Fitó M., Salas-Salvadó J., Martínez-González M.A., Lamuela-Raventós R., et al. Effects of 1-year intervention with a Mediterranean diet on plasma fatty acid composition and metabolic syndrome in a population at high cardiovascular risk. PLoS ONE. 2014;9:e85202. doi: 10.1371/journal.pone.0085202. - DOI - PMC - PubMed
-
- Sofi F., Dinu M., Pagliai G., Cesari F., Marcucci R., Casini A. Mediterranean versus vegetarian diet for cardiovascular disease prevention (the CARDIVEG study): Study protocol for a randomized controlled trial. Trials. 2016;17:233. doi: 10.1186/s13063-016-1353-x. Erratum in Trials 2016, 17, 253. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous